Insulin Savings for Patients Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 18, 2022)
Insulin Savings for Patients Act
This bill requires 100% of negotiated price concessions for covered insulin products under the Medicare prescription drug benefit to be reflected at the point of sale by 2024. The Government Accountability Office must annually report on the effects of the bill's implementation, including with respect to insulin prices.
What just happenedFeb 21, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 18, 2022
- Feb 21, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 18, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Feb 18, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Feb 18, 2022IntroReferralIntro-H
Introduced in House
- Feb 18, 2022IntroReferral1000
Introduced in House